Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem

References

1. Anderson J. D., Sykes R. B. 1973; Characterisation of a β-lactamase obtained from a strain of Bacteroides fragilis resistant to β-lactam antibiotics. Journal of Medical Microbiology 6:201–206
   [Google Scholar]
2. Cuchural G. J., Tally F. P., Jacobus N. V., Marsh P. K., Mayhew J. W. 1983; Cefoxitin inactivation by Bacteroides fragilis. Antimicrobial Agents and Chemotherapy 24:936–940
   [Google Scholar]
3. Eley A., Greenwood D. 1981; In-vitro activity of ceftizoxime against Bacteroides fragilis: comparison with benzylpenicil-lin, cephalothin and cefoxitin. Antimicrobial Agents and Chemotherapy 20:332–335
   [Google Scholar]
4. Eley A., Ambler J., Greenwood D. 1983; Isoelectric focusing of β-lactamases on cellulose acetate membranes. Journal of Antimicrobial Chemotherapy 12:193–196
   [Google Scholar]
5. Eley A., Greenwood D. 1984; Variations in susceptibility to latamoxef (moxalactam) and cefoxitin within the Bacteroides fragilis group. Journal of Antimicrobial Chemotherapy 13:245–255
   [Google Scholar]
6. Foulstone M., Reading C. 1982; Assay of amoxycillin and clavulanic acid, the components of augmentin in biological fluids with high-performance liquid chromatography. Antimicrobial Agents and Chemotherapy 22:753–762
   [Google Scholar]
7. Holdeman L. V., Cato E. P., Moore W. E. C. 1977 Anaerobe laboratory manual, 4th edn.. Virginia Polytechnic Institute and State University; Blacksburg, VA:
   [Google Scholar]
8. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. 1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193:265–275
   [Google Scholar]
9. Nord C. E., Olsson-Liljequist B. 1981; Resistance to β-lactam antibiotics in Bacteroides species. Journal of Antimicrobial Chemotherapy8 Suppl D:33–42
   [Google Scholar]
10. O’Grady F., Eley A. 1983; Continuous opacity monitoring of the growth of bacteria under strict anaerobic conditions. Journal of Clinical Pathology 36:1229–32
    [Google Scholar]
11. Olsson B., Nord C. E., Wadström T. 1976; Formation of Beta-lactamase in Bacteroides fragilis: cell-bound and extracellular activity. Antimicrobial Agents and Chemotherapy 9:727–735
    [Google Scholar]
12. Sato K., Matsuura Y., Inoue M., Mitsuhashi S. 1982; Properties of a new penicillinase type produced by Bacteroides fragilis. Antimicrobial Agents and Chemotherapy 22:579–584
    [Google Scholar]
13. Simpson I. N., Page C. D., Harper P. B. 1982; The contribution of β-lactamases to β-lactam resistance in Bacteroides fragilis. Journal of Antimicrobial Chemotherapy 9:29–45
    [Google Scholar]
14. Tajima M., Sawa K., Watanabe K., Ueno K. 1983; The β-lactamases of genus Bacteroides. Journal of Antibiotics 36:423–428
    [Google Scholar]
15. Tally F. P., Jacobus N. V. 1983; Susceptibility of anaerobic bacteria to imipenem. Journal of Antimicrobial Chemotherapy12 Suppl D:47–51
    [Google Scholar]
16. Timewell R., Taylor E., Phillips I. 1981; The ^-lactamases of Bacteroides species. Journal of Antimicrobial Chemotherapy 7:137–146
    [Google Scholar]
17. Yotsuji A., Minami S., Inoue M., Mitsuhashi S. 1983; Properties of novel β-lactamase produced by Bacteroides fragilis. Antimicrobial Agents and Chemotherapy 24:925–929
    [Google Scholar]